These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14161407)

  • 1. FIBRIN SUSPENSION ASSAY FOR FIBRINOLYTIC ACTIVITY.
    DYER AE; KADAR D
    Blood; 1964 Jun; 23():729-40. PubMed ID: 14161407
    [No Abstract]   [Full Text] [Related]  

  • 2. Assay of thrombolytic ('fibrinolytic') mixtures intended for therapeutic use.
    FLETCHER AP; ALKJAERSIG N; SHERRY S
    J Lab Clin Med; 1961 Apr; 57():620-9. PubMed ID: 13700257
    [No Abstract]   [Full Text] [Related]  

  • 3. Dyed fibrin plate assay of fibrinolysis.
    Barta G
    Can J Physiol Pharmacol; 1966 Mar; 44(2):233-40. PubMed ID: 5946561
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinolysis. V. The thrombolytic and anticoagulant activity of mold fibrinolysin (Aspergillin O) in vivo.
    MARIN HM; STEFANINI M; SOARDI F; MUELLER L
    J Lab Clin Med; 1961 Jul; 58():47-59. PubMed ID: 13766766
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrinolysis. I. Fibrinolytic activity of extracts from non-pathogenic fungi.
    STEFANINI M; MARIN H
    Proc Soc Exp Biol Med; 1958 Nov; 99(2):504-7. PubMed ID: 13601918
    [No Abstract]   [Full Text] [Related]  

  • 6. [Physiology of hemostasis. II. Fibrinolysis].
    Sultan Y; Caen J; Allain JP; Meyer D
    Pathol Biol (Paris); 1969 May; 17(9):529-34. PubMed ID: 4240805
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of fibrinolytic activity by a zymogram technique after isoelectric focusing.
    Vesterberg O; Eriksson R
    Biochim Biophys Acta; 1972 Dec; 285(2):393-7. PubMed ID: 4267029
    [No Abstract]   [Full Text] [Related]  

  • 8. Some aspects of fibrin clot lysis and its inhibition by human serum.
    Gallimore MJ; Shaw JT
    Thromb Diath Haemorrh; 1967 Aug; 18(1-2):101-13. PubMed ID: 4229207
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrinolysis. VII. Clot lysis, coagulation, and fibrinolytic mechanisms after administration of aspergillin O (mold fibrinolysin) in man.
    KARACA M; STEFANINI M; MELE R
    J Lab Clin Med; 1962 May; 59():799-814. PubMed ID: 14453834
    [No Abstract]   [Full Text] [Related]  

  • 10. CURRENT STATUS OF THROMBOLYTIC THERAPY.
    SHERRY S
    Geriatrics; 1964 Sep; 19():628-43. PubMed ID: 14221883
    [No Abstract]   [Full Text] [Related]  

  • 11. CURRENT APPRAISAL OF THROMBOLYTIC THERAPY. A CRITICAL REVIEW.
    LIEBERMAN J
    Calif Med; 1963 Nov; 99(5):301-7. PubMed ID: 14081772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmin potency estimates: influence of the substrate used in assay.
    Philo RD; Gaffney PJ
    Thromb Haemost; 1981 Apr; 45(2):107-9. PubMed ID: 6454987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and properties of aspergillopeptidase from Aspergillus fumigatus.
    K edziora K
    Acta Biochim Pol; 1971; 18(2):109-19. PubMed ID: 4329486
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibrinolytic therapy: biochemical mechanisms.
    Robbins KC
    Semin Thromb Hemost; 1991 Jan; 17(1):1-6. PubMed ID: 1828622
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasminogen activators: pharmacology and therapy.
    Holden RW
    Radiology; 1990 Mar; 174(3 Pt 2):993-1001. PubMed ID: 2137641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preparative isolation of terrilytin components and study of their enzymatic properties].
    Selezneva AA; Babenko GA; Bol'shakova MD; Rozhanskaia TI; Margolina NA
    Prikl Biokhim Mikrobiol; 1976; 12(3):416-20. PubMed ID: 11462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo fibrinolytic activity and pharmacology of various plasmin (fibrinolysin) preparations.
    BACK N; AMBRUS JL; GOLDSTEIN S; HARRISSON JW
    Circ Res; 1956 Jul; 4(4):440-3. PubMed ID: 13330188
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fibrinolysis and fibrinolytic hemorrhagic diatheses].
    FAVRE-GILLY J; POTTON F
    J Med Lyon; 1952 Oct; 33(786):869-81. PubMed ID: 13023221
    [No Abstract]   [Full Text] [Related]  

  • 19. ACTIVATION OF FIBRINOLYTIC ENZYMES IN BANK BLOOD BY ADDITION OF SYNTHETIC COMPOUNDS. RELATION OF ACTIVITY TO CHEMICAL STRUCTURE.
    VONKAULLA KN
    Bibl Haematol; 1964; 19():174-81. PubMed ID: 14266993
    [No Abstract]   [Full Text] [Related]  

  • 20. ENZYMATIC AND PHYSIOLOGICAL STUDIES ON THE PROTEASES HETEROGENOUS TO THE BODY. I. SUBSTRATE SPECIFICITY, INHIBITORS, AND THE PHYSIOLOGICAL FATE OF ASPERKINASE.
    OSHIBA S; MIHARA H; HATA S; OKAMOTO S
    Kobe J Med Sci; 1963 Dec; 18():139-49. PubMed ID: 14160534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.